Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Vetwise ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.4% 1.3% 1.4% 1.4% 7.3% 3.7% 13.4% 13.4%   Credit score (0-100)   49 81 77 77 33 50 17 17   Credit rating   BBB A A A BBB BBB BB BB   Credit limit (kDKK)   0.0 20.5 11.3 16.4 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   765 942 1,246 973 6.9 95.3 0.0 0.0   EBITDA   169 331 622 328 -570 63.2 0.0 0.0   EBIT   -281 295 550 311 -587 45.8 0.0 0.0   Pre-tax profit (PTP)   -339.0 385.1 374.0 511.2 -811.8 117.0 0.0 0.0   Net earnings   -395.2 334.8 275.0 397.2 -811.8 117.0 0.0 0.0   Pre-tax profit without non-rec. items   -339 385 374 511 -812 117 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   210 2,376 2,303 148 130 113 0.0 0.0   Shareholders equity total   1,122 1,349 1,513 1,797 871 988 741 741   Interest-bearing liabilities   0.0 2,175 2,175 0.0 115 0.0 0.0 0.0   Balance sheet total (assets)   1,216 3,740 4,064 1,978 1,036 1,054 741 741   Net Debt   -799 1,122 667 -1,704 -671 -896 -741 -741     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   765 942 1,246 973 6.9 95.3 0.0 0.0   Gross profit growth   -6.6% 23.2% 32.3% -21.9% -99.3% 1,277.6% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,216 3,740 4,064 1,978 1,036 1,054 741 741   Balance sheet change%   -29.9% 207.5% 8.6% -51.3% -47.6% 1.7% -29.7% 0.0%   Added value   168.8 330.7 622.2 327.9 -569.5 63.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -900 2,130 -145 -2,173 -35 -35 -113 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -36.8% 31.3% 44.1% 31.9% -8,487.7% 48.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -16.4% 17.4% 15.4% 18.5% -38.0% 12.2% 0.0% 0.0%   ROI %   -17.7% 18.6% 16.7% 20.3% -41.2% 13.0% 0.0% 0.0%   ROE %   -28.8% 27.1% 19.2% 24.0% -60.9% 12.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   92.2% 36.1% 37.2% 90.8% 84.1% 93.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -473.7% 339.1% 107.3% -519.6% 117.8% -1,417.1% 0.0% 0.0%   Gearing %   0.0% 161.3% 143.8% 0.0% 13.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.3% 10.5% 4.3% 417.1% 19.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   10.6 6.3 4.7 10.1 5.5 14.2 0.0 0.0   Current Ratio   10.6 6.3 4.7 10.1 5.5 14.2 0.0 0.0   Cash and cash equivalent   799.5 1,053.4 1,507.6 1,703.8 785.5 895.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   463.4 275.5 79.5 -12.1 -41.0 313.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   169 331 622 328 -570 63 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   169 331 622 328 -570 63 0 0   EBIT / employee   -281 295 550 311 -587 46 0 0   Net earnings / employee   -395 335 275 397 -812 117 0 0